Widely read:
Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the 3rd quarter and nine months ended 31st December 2025 Standalone and Consolidated Unaudited Financial Results for the 3rd quarter and nine months ended 31st December 2025
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
